MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

Filter Criteria [Hide filter]
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
Too much news? Try filtering with NewsWatch. Alternatively, try our Desktop News Alert.

The following articles are from the past month only. Click here for older news.
 
First     Previous     Next
22/04/24 06:02 (GSK) Director Deals - (GSK) BFN
22/04/24 06:02 (GSK) Director Deals - (GSK) BFN
18/04/24 06:02 (GSK) Director Deals - (GSK) BFN
18/04/24 06:02 (GSK) Director Deals - (GSK) BFN
18/04/24 06:02 (GSK) Director Deals - (GSK) BFN
18/04/24 06:02 (GSK) Director Deals - (GSK) BFN
18/04/24 06:02 (GSK) Director Deals - (GSK) BFN
18/04/24 06:02 (GSK) Director Deals - (GSK) BFN
17/04/24 08:46 Gsk PLC (GSK) TOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea treatment ALN
16/04/24 15:02 (GSK) Director Deals - (GSK) BFN
16/04/24 15:02 (GSK) Director Deals - (GSK) BFN
16/04/24 15:02 (GSK) Director Deals - (GSK) BFN
16/04/24 15:02 (GSK) Director Deals - (GSK) BFN
16/04/24 15:02 (GSK) Director Deals - (GSK) BFN
16/04/24 15:02 (GSK) Director Deals - (GSK) BFN
16/04/24 15:02 (GSK) Director Deals - (GSK) BFN
16/04/24 15:02 (GSK) Director Deals - (GSK) BFN
16/04/24 15:02 (GSK) Director Deals - (GSK) BFN
16/04/24 15:02 (GSK) Director Deals - (GSK) BFN
16/04/24 15:02 (GSK) Director Deals - (GSK) BFN
16/04/24 15:02 (GSK) Director Deals - (GSK) BFN
16/04/24 08:59 Gsk PLC (GSK) GSK’s latest meningitis vaccine accepted for review by US regulator ALN
25/03/24 06:01 (GSK) Director Deals - (GSK) BFN
25/03/24 06:01 (GSK) Director Deals - (GSK) BFN
25/03/24 06:01 (GSK) Director Deals - (GSK) BFN
25/03/24 06:01 (GSK) Director Deals - (GSK) BFN
25/03/24 06:01 (GSK) Director Deals - (GSK) BFN
25/03/24 06:01 (GSK) Director Deals - (GSK) BFN
25/03/24 06:01 (GSK) Director Deals - (GSK) BFN
25/03/24 06:01 (GSK) Director Deals - (GSK) BFN
25/03/24 06:01 (GSK) Director Deals - (GSK) BFN
25/03/24 06:01 (GSK) Director Deals - (GSK) BFN
18/03/24 08:47 Gsk PLC (GSK) GSK says Jemperli combination gets good results for endometrial cancer ALN
14/03/24 06:02 (GSK) Director Deals - (GSK) BFN
14/03/24 06:02 (GSK) Director Deals - (GSK) BFN
14/03/24 06:01 (GSK) Director Deals - (GSK) BFN
14/03/24 06:01 (GSK) Director Deals - (GSK) BFN
07/03/24 09:38 Gsk PLC (GSK) GSK observes positive data in Blenrep trial for blood cancer treatment ALN
05/03/24 11:03 Gsk PLC (GSK) GSK says ViiV’s cabotegravir study supports longer HIV dose interval ALN
29/02/24 09:44 Gsk PLC (GSK) TOP NEWS: GSK avoids ‘protracted litigation’ with Zantac settlement ALN
27/02/24 06:01 (GSK) Director Deals - (GSK) BFN
27/02/24 06:01 (GSK) Director Deals - (GSK) BFN
26/02/24 08:25 Gsk PLC (GSK) GSK gonorrhoea treatment achieves efficacy endpoint in latest trial ALN
21/02/24 09:47 Gsk PLC (GSK) GSK reports encouraging results for ViiV’s Cabenuva HIV treatment ALN
20/02/24 15:01 (GSK) Director Deals - (GSK) BFN
20/02/24 15:01 (GSK) Director Deals - (GSK) BFN
16/02/24 06:02 (GSK) Director Deals - (GSK) BFN
16/02/24 06:02 (GSK) Director Deals - (GSK) BFN
16/02/24 06:02 (GSK) Director Deals - (GSK) BFN
16/02/24 06:02 (GSK) Director Deals - (GSK) BFN
First     Previous     Next